Healio3d
Patients with PAH show more benefit with seralutinib if deemed responders
Among patients with pulmonary arterial hypertension treated with 72-week seralutinib, those deemed responders had more ...
Spurs' Victor Wembanyama diagnosed with deep vein thrombosis. Explaining the condition
San Antonio Spurs superstar Victor Wembanyama will likely miss the rest of the season because of deep vein thrombosis. What ...
Future Market Insights6d
Pulmonary Arterial Hypertension Treatment Market to Reach USD 7,224.4 Million by 2033 at a 2.2% of CAGR
The PAH treatment market is expected to grow from USD 5,811.5 million in 2023 to USD 7,224.4 million by 2033, at a CAGR of ...
Pulmonaryhypertensionnews.com2d
Diaphragm neurostimulation eases PH during mechanical ventilation
The AeroNova neurostimulation system reduced PH among critically ill patients with lung failure who were on mechanical ...
Daxor Corporation Announces New Data on Blood Volume Analysis from Duke and Yale Universities Presented at THT 2025
Two Groundbreaking Studies on Fluid Management: Pulmonary Artery Pressure Monitoring Falls Short, New Diuretic Insights Emerge ...
MassDevice3d
Data backs Lungpacer Medical’s diaphragm neurostim
Lungpacer Medical today announced positive results from a Phase 1 clinical study evaluating its neurostimulation technology ...
Daxor reports new studies using Blood Volume Analysis technology
Daxor (DXR) announces new studies from Duke University Medical Center and Yale School of Medicine, presented at the Technology and Heart ...